---
title: "603648.SH (603648.SH) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/603648.SH/news.md"
symbol: "603648.SH"
name: "603648.SH"
parent: "https://longbridge.com/en/quote/603648.SH.md"
datetime: "2026-05-21T00:35:43.556Z"
locales:
  - [en](https://longbridge.com/en/quote/603648.SH/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/603648.SH/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/603648.SH/news.md)
---

# 603648.SH (603648.SH) — Related News

### [SLC released its first-quarter performance, with a net profit attributable to the parent company of 33.27 million yuan, a year-on-year increase of 4.96%](https://longbridge.com/en/news/284106233.md)
*2026-04-26T09:22:04.000Z*
> SLC released its first-quarter performance for 2026, with revenue of 367 million yuan, a year-on-year increase of 5.30%;

### [SLC's net profit attributable to the parent company for the year 2025 is 123 million yuan, a year-on-year decrease of 5.89%](https://longbridge.com/en/news/277768883.md)
*2026-03-04T11:17:02.000Z*
> SLC released its performance preliminary report for the year 2025, with total operating revenue of 1.537 billion yuan, a

### [DZT: Sold part of its listed company shares, with a cumulative profit and loss of approximately 166 million yuan](https://longbridge.com/en/news/273807106.md)
*2026-01-27T07:55:39.000Z*
> DZT announced that from February 13, 2025, to January 26, 2026, the company reduced its holdings in certain listed compa

### [SLC and WGQ jointly established a pharmaceutical company](https://longbridge.com/en/news/266456356.md)
*2025-11-19T01:02:31.000Z*
> According to the Qichacha APP, recently, Shanghai SLC Baifu Pharmaceutical Co., Ltd. was established with a registered c

### [SLC directors plan to reduce their holdings by no more than 0.77% of shares](https://longbridge.com/en/news/265499953.md)
*2025-11-12T11:07:07.000Z*
> SLC announced that the company's director Xu Feng plans to reduce his holdings by no more than 2.0652 million shares thr

### [SLC: Directors Xu Feng and Chen Wenye plan to reduce their holdings by 0.57% and 0.20% respectively](https://longbridge.com/en/news/265491204.md)
*2025-11-12T10:27:08.000Z*
> SLC announced that directors Xu Feng and Chen Wenye plan to reduce their holdings by 0.57% and 0.20%, respectively. Xu F

### [SLC: As a limited partner, it does not participate in the daily operations and investment decisions of the fund](https://longbridge.com/en/news/256526355.md)
*2025-09-09T09:44:46.000Z*
> SLC responded to investor inquiries on the interactive platform, stating that the company, as a limited partner, does no

### [SLC released its semi-annual performance report, with a net profit attributable to the parent company of 68.31 million yuan, a year-on-year decrease of 14.62%](https://longbridge.com/en/news/254980821.md)
*2025-08-28T10:46:07.000Z*
> According to the Zhitong Finance APP, SLC disclosed its semi-annual report for 2025. During the reporting period, the co

### [SLC: Plans to establish a joint venture with a biopharmaceutical company, with a registered capital of 50 million yuan](https://longbridge.com/en/news/254948888.md)
*2025-08-28T08:15:03.000Z*
> SLC announced a joint venture with Shanghai Waigaoqiao Biomedical Industry Development Co., Ltd. to establish Shanghai C